Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Raptopoulou M"'
Autor:
Liampas, I. *, Papathanasiou, S., Tsikritsis, N., Roka, V., Roustanis, A., Ntontos, T., Kyriakopoulos, C., Raptopoulou, M., Eythimiadi, G., Giakimova-Polyzou, V., Kalliora, C., Tasios, V., Papageorgiou, A., Dardiotis, E.
Publikováno v:
In Revue Neurologique December 2021 177(10):1283-1293
Autor:
Paraskevis, D., Haida, C., Tassopoulos, N., Raptopoulou, M., Tsantoulas, D., Papachristou, H., Sypsa, V., Hatzakis, A. *
Publikováno v:
In Journal of Virological Methods 2002 103(2):201-212
Autor:
Raptopoulou, M.1 mrapto@med.auth.gr, Touloumi, G.2, Tzourmakliotis, D.3, Nikolopoulou, G.4, Dimopoulou, M.5, Giannoulis, G.6, Vasiliadis, T.7, Skoutelis, A.8, Anagnostou, O.2, Hatzis, G.9, Manolakopoulos, S.3
Publikováno v:
Hippokratia. Jan2011, Vol. 15 Issue 1, p26-31. 6p. 2 Charts, 2 Graphs.
Autor:
Raptopoulou, M.1 mrapto@med.auth.gr, Papatheodoridis, G.2, Antoniou, A.3, Ketikoglou, J.4, Tzourmakliotis, D.5, Vasiliadis, T.6, Manolaki, N.7, Nikolopoulou, G.8, Manesis, E.2, Pierroutsakos, I.8
Publikováno v:
Journal of Viral Hepatitis. Mar2009, Vol. 16 Issue 3, p195-202. 8p. 3 Charts, 2 Graphs.
Autor:
Raptopoulou, M.1 mrapto@med.auth.gr, Tsantoulas, D.2, Vafiadi, I.3, Ketikoglou, I.4, Paraskevas, E.5, Vassiliadis, T.6, Kanatakis, S.7, Hatzis, G.3, Sidiropoulos, L.8, Akriviadis, E.1
Publikováno v:
Journal of Viral Hepatitis. Jan2005, Vol. 12 Issue 1, p91-95. 5p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide. Greece belongs to the intermediate endemicity countries with a trend of decreasing prevalence of HBV infection during the last decade. However, the recent mass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::093f92d4246646ec431c600a4815f843
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004403
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3004403
We studied viral dynamic parameters in 44 chronic hepatitis B/hepatitis B e antigen (HBeAg)(-) patients treated with pegylated interferon alfa-2b (PEG-IFN) 100 or 200 mu g weekly or lamivudine 100 mg daily or the combination of PEG-IFN 100 or 200 mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::b79f46a4d1227d51581190544934a345
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3096834
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3096834
Autor:
Raptopoulou, M.1, Goulis, G.1
Publikováno v:
Clinical & Experimental Immunology. Jun1977, Vol. 28 Issue 3, p458-460. 3p.